Roche Holdings AG focuses on neurology, oncology, immunology, ophthalmology, and cardiovascular diseases. They aim to accelerate drug development, cut costs, and launch transformative medicines by 2030. Roche recently acquired assets for obesity and breast cancer, enhancing their portfolio.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing